CNS Malignancy
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cognitive Function After Treatment of Primary CNS Malignancy (NCT03055364) | Mayo Clinic | 2017-06-13 |
| Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors (NCT01639911) | University of Illinois at Chicago | 2013-08-14 |
Track CNS Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.